| Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and … MG Thompson MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 818 | 2021 |
| Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines MG Thompson, JL Burgess, AL Naleway, H Tyner, SK Yoon, J Meece, ... New England Journal of Medicine 385 (4), 320-329, 2021 | 510 | 2021 |
| Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B. 1.617. 2 (Delta) variant predominance—eight US locations … A Fowlkes MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 327 | 2021 |
| Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5–11 years and adolescents aged 12–15 years—PROTECT … AL Fowlkes MMWR. Morbidity and mortality weekly report 71, 2022 | 167 | 2022 |
| Protection with a third dose of mRNA vaccine against SARS-CoV-2 variants in frontline workers SK Yoon, KT Hegmann, MS Thiese, JL Burgess, K Ellingson, K Lutrick, ... New England Journal of Medicine 386 (19), 1855-1857, 2022 | 42 | 2022 |
| Association of mRNA vaccination with clinical and virologic features of COVID-19 among US essential and frontline workers G Joseph, J Barnes, E Azziz-Baumgartner, M Arvay, A Fry, A Hall, P Kutty, ... Jama 328 (15), 1523-1533, 2022 | 27 | 2022 |
| Research on the epidemiology of SARS-CoV-2 in essential response personnel (RECOVER): protocol for a multisite longitudinal cohort study LJ Edwards, AL Fowlkes, MG Wesley, JL Kuntz, MJ Odean, ... JMIR research protocols 10 (12), e31574, 2021 | 19 | 2021 |
| COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers K Lutrick, H Groom, AL Fowlkes, KD Groover, M Gaglani, P Rivers, ... Vaccine 40 (3), 494-502, 2022 | 12 | 2022 |
| Risk factors for reinfection with SARS-CoV-2 Omicron variant among previously infected frontline workers KD Ellingson, J Hollister, CJ Porter, SM Khan, LR Feldstein, AL Naleway, ... Emerging infectious diseases 29 (3), 599, 2023 | 8 | 2023 |
| Neutralizing antibody response to pseudotype severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differs between mRNA-1273 and BNT162b2 coronavirus disease 2019 (COVID … HL Tyner, JL Burgess, L Grant, M Gaglani, JL Kuntz, AL Naleway, ... Clinical infectious diseases 75 (1), e827-e837, 2022 | 8 | 2022 |
| Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US … AL Naleway, L Grant, AJ Caban‐Martinez, MG Wesley, JL Burgess, ... Influenza and other respiratory viruses 16 (3), 585-593, 2022 | 6 | 2022 |
| Neutralizing antibody response to pseudotype sars-cov-2 differs between mRNA-1273 and Bnt162b2 covid-19 vaccines and by history of sars-cov-2 infection HL Tyner, JL Burgess, L Grant, M Gaglani, JL Kuntz, AL Naleway, ... medRxiv, 2021.10. 20.21265171, 2021 | 6 | 2021 |
| 1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in US Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022 AR Yousaf, J Mak, L Gwynn, R Bloodworth, R Rai, Z Jeddy, LB LeClair, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2466, 2023 | 4 | 2023 |
| Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): protocol for a multisite longitudinal cohort study J Burns, P Rivers, LB LeClair, KS Jovel, RP Rai, AA Lowe, LJ Edwards, ... JMIR research protocols 11 (7), e37929, 2022 | 4 | 2022 |
| The role of elbow tender point examination in the diagnosis of lateral epicondylitis SK Yoon, MS Thiese, U Ott, J Kapellusch, A Merryweather, EM Wood, ... Journal of occupational and environmental medicine 61 (2), 126-131, 2019 | 4 | 2019 |
| Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses MK Herring, JK Romine, MG Wesley, KD Ellingson, SK Yoon, ... Clinical Infectious Diseases 76 (10), 1822-1831, 2023 | 3 | 2023 |
| Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years LR Feldstein, A Britton, L Grant, R Wiegand, J Ruffin, TM Babu, MB Hagen, ... JAMA 331 (5), 408-416, 2024 | 2 | 2024 |
| Detection and stability of SARS-CoV-2 in three self-collected specimen types: Flocked Midturbinate Swab (MTS) in viral transport media, foam MTS, and Saliva V Veguilla, AL Fowlkes, A Bissonnette, S Beitel, M Gaglani, CA Porucznik, ... Microbiology spectrum 10 (3), e01033-22, 2022 | 2 | 2022 |
| Serum per-and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies J Hollister, AJ Caban-Martinez, KD Ellingson, S Beitel, AL Fowlkes, ... Environmental research 239, 117297, 2023 | 1 | 2023 |
| Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study JK Romine, H Li, MM Coughlin, JM Jones, A Britton, HL Tyner, SB Fuller, ... Clinical Infectious Diseases, ciae130, 2024 | | 2024 |
